| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium channel regulator activity | 4.65e-05 | 54 | 26 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 5.84e-05 | 9 | 26 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 5.84e-05 | 9 | 26 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.61e-04 | 27 | 26 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.19e-03 | 162 | 26 | 3 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.46e-03 | 174 | 26 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.53e-03 | 177 | 26 | 3 | GO:0141108 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.60e-03 | 560 | 26 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 5.82e-03 | 566 | 26 | 4 | GO:0001216 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 4.65e-05 | 9 | 24 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 1.54e-04 | 16 | 24 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.54e-04 | 16 | 24 | 2 | GO:0007158 | |
| HumanPheno | Congenital, generalized hypertrichosis | 1.27e-05 | 3 | 11 | 2 | HP:0004540 | |
| Domain | GPCR_3_mtglu_rcpt | 5.19e-05 | 8 | 26 | 2 | IPR000162 | |
| Domain | NCD3G | 1.44e-04 | 13 | 26 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.44e-04 | 13 | 26 | 2 | IPR011500 | |
| Domain | GPCR_3_CS | 1.68e-04 | 14 | 26 | 2 | IPR017979 | |
| Domain | EGF | 2.94e-04 | 235 | 26 | 4 | SM00181 | |
| Domain | EGF-like_dom | 3.66e-04 | 249 | 26 | 4 | IPR000742 | |
| Domain | GPCR_3 | 3.85e-04 | 21 | 26 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 4.23e-04 | 22 | 26 | 2 | PS50259 | |
| Domain | 7tm_3 | 4.23e-04 | 22 | 26 | 2 | PF00003 | |
| Domain | GPCR_3_C | 4.23e-04 | 22 | 26 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 4.23e-04 | 22 | 26 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 4.23e-04 | 22 | 26 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 4.23e-04 | 22 | 26 | 2 | PS00979 | |
| Domain | EGF | 6.96e-04 | 126 | 26 | 3 | PF00008 | |
| Domain | zf-C2H2_6 | 8.75e-04 | 314 | 26 | 4 | PF13912 | |
| Domain | ANF_receptor | 1.20e-03 | 37 | 26 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.20e-03 | 37 | 26 | 2 | IPR001828 | |
| Domain | VWC | 1.27e-03 | 38 | 26 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.27e-03 | 38 | 26 | 2 | PS50184 | |
| Domain | Peripla_BP_I | 1.34e-03 | 39 | 26 | 2 | IPR028082 | |
| Domain | VWF_dom | 1.55e-03 | 42 | 26 | 2 | IPR001007 | |
| Domain | - | 2.18e-03 | 679 | 26 | 5 | 3.30.160.60 | |
| Domain | zf-C2H2 | 2.38e-03 | 693 | 26 | 5 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.40e-03 | 694 | 26 | 5 | IPR013087 | |
| Domain | Laminin_G | 2.94e-03 | 58 | 26 | 2 | IPR001791 | |
| Domain | ZINC_FINGER_C2H2_2 | 3.86e-03 | 775 | 26 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 3.91e-03 | 777 | 26 | 5 | PS00028 | |
| Domain | EGF_3 | 4.13e-03 | 235 | 26 | 3 | PS50026 | |
| Domain | Znf_C2H2-like | 4.33e-03 | 796 | 26 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 4.54e-03 | 805 | 26 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 4.62e-03 | 808 | 26 | 5 | SM00355 | |
| Domain | EGF_1 | 5.18e-03 | 255 | 26 | 3 | PS00022 | |
| Domain | EGF-like_CS | 5.53e-03 | 261 | 26 | 3 | IPR013032 | |
| Domain | EGF_2 | 5.77e-03 | 265 | 26 | 3 | PS01186 | |
| Domain | - | 7.68e-03 | 95 | 26 | 2 | 2.60.120.200 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.41e-04 | 15 | 22 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.41e-04 | 15 | 22 | 2 | MM15845 | |
| Pubmed | ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia. | 5.37e-07 | 2 | 26 | 2 | 28412727 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 12393497 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 24891617 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 1.61e-06 | 3 | 26 | 2 | 26788497 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 14630787 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 9920659 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 2.41e-05 | 10 | 26 | 2 | 9069281 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 17156446 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 11891216 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 6.41e-05 | 16 | 26 | 2 | 17521568 | |
| Pubmed | 6.98e-05 | 300 | 26 | 4 | 19086053 | ||
| Pubmed | PDGFRα controls the balance of stromal and adipogenic cells during adipose tissue organogenesis. | 9.12e-05 | 19 | 26 | 2 | 28049691 | |
| Pubmed | 9.12e-05 | 19 | 26 | 2 | 24165912 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.28e-04 | 351 | 26 | 4 | 38297188 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.47e-04 | 24 | 26 | 2 | 35746896 | |
| Pubmed | 3.72e-04 | 38 | 26 | 2 | 25613138 | ||
| Pubmed | 5.09e-04 | 210 | 26 | 3 | 16537572 | ||
| Pubmed | 5.22e-04 | 45 | 26 | 2 | 25979088 | ||
| Pubmed | 6.96e-04 | 52 | 26 | 2 | 19328558 | ||
| Interaction | GLI2 interactions | 7.54e-06 | 99 | 26 | 4 | int:GLI2 | |
| Interaction | GLI1 interactions | 4.87e-05 | 159 | 26 | 4 | int:GLI1 | |
| Interaction | GRM4 interactions | 8.74e-05 | 11 | 26 | 2 | int:GRM4 | |
| Interaction | ZNF423 interactions | 1.12e-04 | 73 | 26 | 3 | int:ZNF423 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.92e-05 | 8 | 19 | 2 | 281 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.12e-04 | 718 | 19 | 5 | 28 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | 6.07e-06 | 424 | 24 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_500 | 1.26e-05 | 129 | 24 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 1.93e-05 | 791 | 24 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 2.17e-05 | 806 | 24 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.00e-05 | 207 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.48e-04 | 243 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#2 | 1.91e-04 | 100 | 24 | 3 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 2.38e-04 | 818 | 24 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 2.38e-04 | 818 | 24 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 2.53e-04 | 827 | 24 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.84e-04 | 288 | 24 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.62e-04 | 307 | 24 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.61e-04 | 135 | 24 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 4.82e-04 | 137 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.92e-04 | 138 | 24 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.39e-04 | 151 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.35e-06 | 142 | 26 | 4 | 1eecbec805a873fa3539df0574670cf73c18c7b1 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-06 | 173 | 26 | 4 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-06 | 173 | 26 | 4 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 3.85e-06 | 185 | 26 | 4 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.75e-06 | 195 | 26 | 4 | 72a7c4beb880390b29f3c5d6dd9dbb082af50fe2 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 5.04e-06 | 198 | 26 | 4 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 5.04e-06 | 198 | 26 | 4 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | 6.13e-06 | 208 | 26 | 4 | 30212cfacad94a7cc562a69efa73a31259851515 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 169 | 26 | 3 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-04 | 170 | 26 | 3 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 171 | 26 | 3 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 171 | 26 | 3 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 173 | 26 | 3 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 173 | 26 | 3 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 173 | 26 | 3 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 173 | 26 | 3 | 5aa4d45a01d2d09eff8b4deb32bd91ab2471210a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 173 | 26 | 3 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 174 | 26 | 3 | 2627c3983009839fedbc5e3f628739dc026447f4 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.38e-04 | 174 | 26 | 3 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 174 | 26 | 3 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 1.38e-04 | 174 | 26 | 3 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 174 | 26 | 3 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 174 | 26 | 3 | 507a33e58f62e2b72f0bcc743e84dbd0bf705a15 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 174 | 26 | 3 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 175 | 26 | 3 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 175 | 26 | 3 | 030f93af5a96848b9118e2a8116e19ddae438d92 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 175 | 26 | 3 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 176 | 26 | 3 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-04 | 180 | 26 | 3 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 181 | 26 | 3 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 1.56e-04 | 181 | 26 | 3 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 1.56e-04 | 181 | 26 | 3 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 182 | 26 | 3 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.61e-04 | 183 | 26 | 3 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.61e-04 | 183 | 26 | 3 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.77e-04 | 189 | 26 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.79e-04 | 190 | 26 | 3 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 190 | 26 | 3 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 191 | 26 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 192 | 26 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 192 | 26 | 3 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.85e-04 | 192 | 26 | 3 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.85e-04 | 192 | 26 | 3 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 193 | 26 | 3 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.88e-04 | 193 | 26 | 3 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.88e-04 | 193 | 26 | 3 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-04 | 193 | 26 | 3 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 193 | 26 | 3 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 194 | 26 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.91e-04 | 194 | 26 | 3 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|tumor_Lung / Location, Cell class and cell subclass | 1.91e-04 | 194 | 26 | 3 | a85d958aff84f2296c330a7dcd442bd2344738df | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-04 | 195 | 26 | 3 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | (5)_Fibroblast-J_(Lipofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.97e-04 | 196 | 26 | 3 | afa29399decd17fda7d63add5039ff778627ccc2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 197 | 26 | 3 | 68d8546dfe7dffd017756a11d3333061f576d0ef | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 197 | 26 | 3 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|COVID-19 / Condition, Lineage and Cell class | 2.00e-04 | 197 | 26 | 3 | b6d6cdae33753c1e38394f1f879e00b87f9c0496 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-04 | 198 | 26 | 3 | c66097ae9ba0b50561083c423565665958ef0bb8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 198 | 26 | 3 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 198 | 26 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-04 | 198 | 26 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | 675f7c56b03a7918e2d9ca99440df6f27ad8e838 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-04 | 199 | 26 | 3 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T|Leuk-UTI / Disease, condition lineage and cell class | 2.06e-04 | 199 | 26 | 3 | aa4d8ce8994e5032a33d5cc68c482882147cdc3b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | 97d74985018816754d11a55b9fb689690ecb1374 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 2.06e-04 | 199 | 26 | 3 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | (5)_Fibroblast-F|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.06e-04 | 199 | 26 | 3 | 1f66db4f502de4a5159cde90fcb3befb26b8d375 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-04 | 200 | 26 | 3 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 200 | 26 | 3 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-04 | 200 | 26 | 3 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 7cea58e2691564e653cc972bf5aaff2df1f2666e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 193c42c31a366a60d80c4c1fc6a1592a5b01a3ad | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 7c780e995a5fc3793080da61b6bf7a12880e9df8 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)----L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | d0b31dc5eedc0635c0d7ceabaa6202386cf2a4a4 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-04 | 200 | 26 | 3 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 8444ae3c10b1152dec67ca812e6c417cc3b9cf89 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-04 | 200 | 26 | 3 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-03 | 96 | 26 | 2 | 78f19fee755061b4144b1beebb60f4e8bc4dbf0d | |
| ToppCell | TCGA-Adrenal-Solid_Tissue_Normal-Adrenal_medulla_normal-Adrenal_medulla-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.85e-03 | 110 | 26 | 2 | 5030985d583a7fbd2fdac2a874c64bbb44bcd829 | |
| ToppCell | TCGA-Adrenal-Solid_Tissue_Normal-Adrenal_medulla_normal|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.85e-03 | 110 | 26 | 2 | 78a41043c7fd58b78f4740dc81ff5b493598a3a6 | |
| Drug | phorbol 12,13-diacetate | 2.21e-05 | 48 | 26 | 3 | CID000072293 | |
| Drug | cis-MCG-I | 3.50e-05 | 8 | 26 | 2 | CID003035584 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 4.49e-05 | 9 | 26 | 2 | CID000107216 | |
| Drug | mM PEP | 4.49e-05 | 9 | 26 | 2 | CID005311462 | |
| Drug | AC1N21PP | 4.49e-05 | 9 | 26 | 2 | CID004014619 | |
| Drug | NS-105 | 5.61e-05 | 10 | 26 | 2 | CID000198695 | |
| Drug | cyclobutylene AP5 | 6.85e-05 | 11 | 26 | 2 | CID000126582 | |
| Drug | panobinostat | 8.17e-05 | 1333 | 26 | 8 | ctd:C496932 | |
| Drug | 2-amino-3-phosphonopropionic acid | 8.79e-05 | 76 | 26 | 3 | CID000003857 | |
| Drug | AC1NSKBB | 9.71e-05 | 13 | 26 | 2 | CID005311256 | |
| Drug | Mspg | 9.71e-05 | 13 | 26 | 2 | CID003964410 | |
| Drug | MSOPPE | 9.71e-05 | 13 | 26 | 2 | CID005311463 | |
| Drug | 2-methyl-6-styrylpyridine | 1.13e-04 | 14 | 26 | 2 | CID000235382 | |
| Drug | MTPG | 1.13e-04 | 14 | 26 | 2 | CID005311456 | |
| Drug | ethylglutamate | 1.49e-04 | 16 | 26 | 2 | CID000014241 | |
| Drug | 2-PMPA | 1.49e-04 | 16 | 26 | 2 | CID010130754 | |
| Drug | 3HPG | 1.69e-04 | 17 | 26 | 2 | CID000001217 | |
| Drug | acromelic acid A | 1.90e-04 | 18 | 26 | 2 | CID000108086 | |
| Drug | aminocyclopentane | 2.12e-04 | 19 | 26 | 2 | CID000002906 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 2.35e-04 | 20 | 26 | 2 | CID000001297 | |
| Drug | tallow | 2.35e-04 | 270 | 26 | 4 | ctd:C013698 | |
| Disease | cognitive function measurement | 8.24e-04 | 1434 | 24 | 6 | EFO_0008354 | |
| Disease | Alcoholic Intoxication, Chronic | 1.30e-03 | 268 | 24 | 3 | C0001973 | |
| Disease | colorectal cancer | 1.33e-03 | 604 | 24 | 4 | MONDO_0005575 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.40e-03 | 68 | 24 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | migraine disorder, endometriosis | 1.61e-03 | 73 | 24 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | smoking status measurement | 2.12e-03 | 1160 | 24 | 5 | EFO_0006527 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.69e-03 | 346 | 24 | 3 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | susceptibility to pneumonia measurement | 2.82e-03 | 97 | 24 | 2 | EFO_0008410 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.48e-03 | 108 | 24 | 2 | DOID:684 (biomarker_via_orthology) | |
| Disease | Substance abuse problem | 4.00e-03 | 116 | 24 | 2 | C0740858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSEDDDSLKCMGYCP | 1366 | Q8WWZ7 | |
| CVSYCESPAAAMDAY | 6 | Q9H161 | |
| PYGANMEDSVCCRDY | 26 | O00626 | |
| PYEYLADEFTCMDCG | 536 | Q14832 | |
| YQGSMECADEPCDAY | 36 | Q8N9N2 | |
| AAGECLCYEGYMKDP | 486 | O14525 | |
| ENEDKYMCESSGFYP | 156 | Q68D85 | |
| KCDSPGMCGYDLYEN | 211 | Q5FYB0 | |
| PYMDQCKDGDITYCE | 891 | Q9P2S2 | |
| SYKAPTFCDYCGEML | 161 | O94806 | |
| DAYPGIYALDCEMCY | 496 | Q8IX06 | |
| EPCDGYQYQFDEMTC | 546 | Q14831 | |
| LCDKCYDDDDYESKM | 1571 | Q03164 | |
| DGPVYEKCMAGDDYC | 701 | Q7Z6B7 | |
| EKCMAGDDYCDSPYS | 706 | Q7Z6B7 | |
| VGTMMTCAYDDPYCE | 211 | Q2TB90 | |
| CFCEDTDYPYLGTTM | 556 | P02786 | |
| PCKDDEYCMEEGGLY | 1076 | O75443 | |
| EAIDCYTKGMDADPY | 151 | Q9H6T3 | |
| TSEPMYGCDICGAAY | 881 | Q96K83 | |
| YHCMSDPEGDYTDPC | 351 | Q7Z698 | |
| PYKCEECGKAYMSYS | 196 | Q8NB50 | |
| PYMCNECGKAFSDSS | 466 | Q8TF39 | |
| HTGEKPYECYDCGQM | 261 | Q96JF6 | |
| ASEPMYGCDICGAAY | 881 | Q2M1K9 | |
| FSDPMYKCECQTGYA | 671 | P35442 | |
| CLDPYYCNKFDGENM | 26 | O94900 |